The queue for power-intensive customers looking to tap into New York’s energy grid has surged as the boom for artificial intelligence and growth in large-scale manufacturing drive electricity demand, ...

Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...

Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...

BOWIE, Md.--(BUSINESS WIRE)--Inovalon, a leading provider of data and solutions empowering data-driven healthcare, recently convened hundreds of healthcare leaders, innovators, and policymakers for ...

SALT LAKE CITY--(BUSINESS WIRE)--ReposiTrak (NYSE:TRAK), the world’s largest food traceability and regulatory compliance network, leveraging its established inventory management and out-of-stock ...

Rishab Shetty's much-anticipated prequel, Kantara Chapter 1, hit theatres on Gandhi Jayanti and collected Rs 60 crore in India on its first day. The film, which follows the 2022 blockbuster Kantara, ...

In his 1960 book Theory and Design in the First Machine Age, the critic and historian Reyner Banham presciently noted a growing chasm between technological change and the capacity of designers to ...

PDVSA launches Blend 22 exports ahead of May 27 license expiry New crude blend being shipped from Western La Salina port Vitol-chartered vessel's hull being cleaned after loading at La Salina Loading ...

We've been rebuilding Aleph from the ground up, and will launch Aleph Pro in October 2025, combining a modern technical foundation with user-centered design and major performance gains. OCCRP’s ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Max Eddy Max Eddy is a writer who has covered privacy and security — including ...

NEW YORK (AP) — 23andMe has filed for Chapter 11 bankruptcy protection and its co-founder and CEO has resigned as the struggling genetic testing company continues its push to cut costs. San ...

The company filed for Chapter 11 bankruptcy to “facilitate a sale process.” Its chief executive stepped down and said she would bid on it. By Yan Zhuang The genetic testing company 23andMe filed for ...